Business
enVVeno Medical Promotes Dr. Hamed Alavi to Senior Vice President and Chief Technology Officer
Dr. Alavi is a highly accomplished medical device executive with proven track record of successfully leading R&D, Quality Assurance, Regulatory Affairs, and
About this update from Envveno Medical Corporation
[{"type":"text","content":"Dr. Alavi is a highly accomplished medical device executive with proven track record of successfully leading R&D, Quality Assurance, Regulatory Affairs, and Manufacturing organizations across a number of companies within the cardiac and vascular spaceIRVINE, CA / ACCESSWIRE / January 18, 2023 / enVVeno Medical Corporation (Nasdaq:NVNO) (\"enVVeno\" or the \"Company\"), a company setting new standards of care for the treatment of venous disease, today announced the promotion of Dr. Hamed Alavi to Senior Vice President and Chief Technology Officer.\"Over the past two and a half years, Hamed's dedication, leadership, and contributions have been outstanding as he has grown to become an invaluable member of our senior management team,\" commented Robert Berman, CEO of enVVeno Medical. \"As just one example, Hamed was the driving force behind the development of enVVe, our transcatheter based replacement venous valve, which went from concept stage to being ready for in-human testing in record time.\"Dr. Alavi joined enVVeno Medical as Director, Research, Development and Quality in July 2020 and was promoted to Vice President of Research, Development and Quality in January 2021. In his new role as Senior Vice President and Chief Technology Officer, Dr. Alavi will seek to incorporate of innovative technologies such as artificial intelligence and cloud-based computing into our existing product mix, while also preparing our manufacturing and quality departments for commercialization of the VenoValve.\"I have been involved with several large and small medical device companies over the course of my career, and I have never come across a company that has as much potential as enVVeno Medical. It is rare to have the opportunity to develop and commercialize a device that is truly new, and that can change the treatment paradigm for millions of patients. With the VenoValve and enVVe, we have two products that could revolutionize the treatment of deep venous CVI, and I am grateful to help lead the talented team and enVVeno to fulfill our potential,\" added Dr. Alavi.Prior to joining enVVeno Medical, Dr. Alavi was the head of engineering at NaviGate Cardiac Structures Inc., a startup which developed tricuspid heart valve replacement and delivery system devices. This and his previous roles at Medtronic Cardiac and Vascular Group (CVG) and Edwards Lif...